Official Journal of Research Center for Gastroenterology and Liver Diseases
OpenAlex
Works that cite this article, indexed by OpenAlex.
Cytokines and Chemokines in HBV Infection
Frontiers in Molecular Biosciences 8 (2021)
Shihong Zhong; Tianling Zhang; Libo Tang; Yongyin Li
Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: A pilot open-label randomized study
Journal of Hepatology 68(6) (2018)
Shishu Zhu; Hongfei Zhang; Yi Dong; Limin Wang; Zhi‐Qiang Xu; Weiwei Liu; Yu Gan; Hongmei Tang; Dawei Chen; Fuchuan Wang; Pan Zhao
Role of Tim-3 in hepatitis B virus infection: An overview
World Journal of Gastroenterology 22(7) (2016)
Yuan Liu; Lifen Gao; Xiaohong Liang; Chunhong Ma
Current concepts on immunopathogenesis of hepatitis B virus infection
Virus Research 245 (2017)
Hadi Peeridogaheh; Zahra Meshkat; Shahram Habibzadeh; Mohsen Arzanlou; Jafar Mohammadshahi; Sina Rostami; Sina Gerayli; Roghayeh Teimourpour
Interleukin-35 modulates the balance between viral specific CD4+CD25+CD127dim/- regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection
Virology Journal 16(1) (2019)
Lanlan Yang; Shengnan Jia; Xue Shao; Siqi Liu; Qian Zhang; Jie Song; Wudong Wang; Zhenjing Jin
Study of the Molecular Dynamics Stability in the Inhibitory Interaction of Tenofovir Disoproxil Fumarate against CTLA-4 in Chronic Hepatitis B Patients
Medical Archives 77(3) (2023)
Darmadi Darmadi; Dharma Lindarto; Jelita Siregar; Tri Widyawati; Muhammad Rusda; Mustafa M. Amin; Fauzi Yusuf; Putri Chairani Eyanoer; Masrul Lubis; Imelda Rey
The impact of currently licensed therapies on viral and immune responses in chronic hepatitis B: Considerations for future novel therapeutics
Journal of Viral Hepatitis 26(1) (2018)
Upkar S. Gill; Patrick T.F. Kennedy
Relationship of Treg/Th17 balance with HBeAg change in HBeAg-positive chronic hepatitis B patients receiving telbivudine antiviral treatment
Medicine 96(23) (2017)
Xiaoling Yang; Jia Li; Jie Liu; Min Gao; Li Zhou; Wei Lü
Sustained Changes of Treg and Th17 Cells During Interferon- α Therapy in Patients with Chronic Hepatitis B
Viral Immunology 28(8) (2015)
Hao Feng; Jie Yin; Yaping Han; Xiaoying Zhou; Su Chen; Li Yang; Jin-Rui Yan; Guoxin Zhang
Circulating IL-1β, IL-17, and IP-10 as Potential Predictors of Hepatitis B Virus Infection Prognosis
Journal of Immunology Research 2022 (2022)
Zhenzhen Su; Jie Chen; Junlong Zhang; Yunfei An; Yun Liao; Xiaojuan Wu; Chuanmin Tao; Lanlan Wang; Bei Cai
Slow reduction of IP-10 Levels predicts HBeAg seroconversion in chronic hepatitis B patients with 5 years of entecavir treatment
Scientific Reports 6(1) (2016)
Renyong Guo; Hejun Mao; Xiao Hu; Nengneng Zheng; Yan Dong; Jianqin He; Jiezuan Yang
Predictive value of Th17 and Treg cells at baseline for HBsAg loss in chronic hepatitis B patients with low HBsAg quantification treated with pegylated interferon and nucleos(t)ide analogue
Liver Research 7(2) (2023)
Lili Wu; Xiaoyan Li; Kai Deng; Bingliang Lin; Hong Xin Deng; Dong‐Ying Xie; Geng-Lin Zhang; Qiyi Zhao; Zhishuo Mo; Yuehua Huang; Zhiliang Gao
Effect of entecavir on CD4+ T-cell subpopulations in patients with chronic hepatitis B.
PubMed 15(2) (2017)
Zhan-Fei Tian; Zhonglan You; Hong Liang Yi; Xuemei Kuang; Yuming Wang
The Effects of Nucleoside/Nucleotide Analogues on Host Immune Cells: The Baseline for Future Immune Therapy for HBV?
Antiviral Therapy 25(4) (2019)
Lauke L. Boeijen; Michelle Spaan; André Boonstra
Th17/Treg cell expression in children with primary nephritic syndrome and the effects of ox-LDL on Th17/Treg cells
Genetics and Molecular Research 15(2) (2016)
Yiran Li; S.G. Wei; Xiao Dong Zhao; Yuhua Jia; Yuxiang Zhang; Shuzhen Sun
Changes of cytokine levels and T cell surface molecules in patients with chronic hepatitis B and the association with functional cure
Journal of Medical Virology 93(8) (2021)
Zhen Xu; Jizong Lin; Yingfu Zeng; Xiao‐hua Yang; Zhe‐bin Wu; Zhaoxia Hu; Qiyi Zhao; Jing Liu; Zhiliang Gao
FoxP3, PD-1 and CTLA-4 are Decreased Significantly After a Tenofovir Therapy in Patients With Chronic Hepatitis B
Future Virology 15(4) (2020)
Hyosun Cho; Hyojeung Kang; Ji Young Kim; Hee Young Kim; Chang W Kim
Factors affecting HBV DNA suppression in chronic hepatitis B patients treated with tenofovir disoproxil fumarate
F1000Research 11 (2022)
Darmadi Darmadi; Dharma Lindarto; Jelita Siregar; Tri Widyawati; Muhammad Rusda; Mustafa M. Amin; Fauzi Yusuf; Putri Chairani Eyanoer; Masrul Lubis; Imelda Rey
Factors affecting HBV DNA suppression in chronic hepatitis B patients treated with tenofovir disoproxil fumarate
F1000Research 11 (2023)
Darmadi Darmadi; Dharma Lindarto; Jelita Siregar; Tri Widyawati; Muhammad Rusda; Mustafa M. Amin; Fauzi Yusuf; Putri Chairani Eyanoer; Masrul Lubis; Imelda Rey
The Influences of Antiviral Therapy on T-cell Function in Adult Patients with Chronic Hepatitis B
Future Virology 9(10) (2014)
S. Harkisoen; Steven Kroon; Karel J. van Erpecum; Andy I. M. Hoepelman; Debbie van Baarle; Joop E. Arends
A Systematic Review of the Frequency of Regulatory T Cells in Hepatitis B and Hepatitis C
The Indonesian Journal of Gastroenterology Hepatology and Digestive Endoscopy 20(3) (2020)
Tri Nugraha Susilawati; Atik Susianto
Regulatory T-cell remodeling across the HBV infection–cirrhosis continuum
Frontiers in Immunology 17 (2026)
YuDan Fu; Yi Wang; Jiqi Ouyang; Wenliang Lv
Langzeittherapie der HBV-Infektion mit oralen Polymeraseinhibitoren
Die Gastroenterologie 10(4) (2015)
Florian van Bömmel; Thomas Berg